DOP2003000759A - ADHESIVE COATED SHEET FOR DERMIC ADMINISTRATION OF A SELECTIVE CYCLLOXYGENASA-2 INHIBITOR - Google Patents
ADHESIVE COATED SHEET FOR DERMIC ADMINISTRATION OF A SELECTIVE CYCLLOXYGENASA-2 INHIBITORInfo
- Publication number
- DOP2003000759A DOP2003000759A DO2003000759A DO2003000759A DOP2003000759A DO P2003000759 A DOP2003000759 A DO P2003000759A DO 2003000759 A DO2003000759 A DO 2003000759A DO 2003000759 A DO2003000759 A DO 2003000759A DO P2003000759 A DOP2003000759 A DO P2003000759A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- subject
- active agent
- composition
- skin
- amount
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composición farmaceutica para la aplicación sobre un area de piel de un sujeto para tratamiento local y/o sistemico de un trastorno mediado por COX-2 comprende una lamina de soporte que se puede adaptar flexiblemente al area de piel, teniendo la lamina de soporte superficies opuestas que son respectivamente distales y proximales a la piel cuando se aplica; y un revestimiento sobre la superficie proximal de la lamina de soporte que comprende (a) un adhesivo y (b) un agente activo que comprende valdecoxib o 1o uno de sus profarmacos o una de sus sales, estando el agente activo en una cantidad total terapeuticamente efectiva y disperso en una matriz que comprende de nada a menos de una cantidad efectiva que solubiliza un agente activo en total de uno o mas disolventes diferentes del adhesivo. Un procedimiento de tratamiento local de un sitio de dolor y/o inflamación en un sujeto comprende la aplicación de la composición sobre la superficie de piel del sujeto, preferiblemente en una localización superpuesta o adyacente al sitio de dolor y/o inflamación, y dejando la composición en el lugar durante un periodo de tiempo efectivo para permitir la liberación de una cantidad localmente terapeutica del agente activo. Un procedimiento de tratamiento sistemico de un sujeto que tiene un trastorno mediado por COX-2 comprende aplicar la composición sobre una superficie de piel del sujeto, y dejar la composición en el lugar durante un periodo de tiempo efectivo para permitir la liberación transdermica de una cantidad terapeutica del agente activo.A pharmaceutical composition for application on a skin area of a subject for local and / or systemic treatment of a COX-2 mediated disorder comprises a support foil that can be flexibly adapted to the skin area, the support foil having surfaces opposites that are respectively distal and proximal to the skin when applied; and a coating on the proximal surface of the support sheet comprising (a) an adhesive and (b) an active agent comprising valdecoxib or one of its prodrugs or one of its salts, the active agent being in a therapeutically total amount effective and dispersed in a matrix comprising nothing less than an effective amount that solubilizes a total active agent of one or more different solvents of the adhesive. A method of local treatment of a site of pain and / or inflammation in a subject comprises the application of the composition on the skin surface of the subject, preferably in a location superimposed or adjacent to the site of pain and / or inflammation, and leaving the composition in place for an effective period of time to allow the release of a locally therapeutic amount of the active agent. A method of systematic treatment of a subject having a COX-2 mediated disorder comprises applying the composition on a subject's skin surface, and leaving the composition in place for an effective period of time to allow transdermal release of an amount. Therapeutics of the active agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DO2003000759A DOP2003000759A (en) | 2003-11-20 | 2003-11-20 | ADHESIVE COATED SHEET FOR DERMIC ADMINISTRATION OF A SELECTIVE CYCLLOXYGENASA-2 INHIBITOR |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DO2003000759A DOP2003000759A (en) | 2003-11-20 | 2003-11-20 | ADHESIVE COATED SHEET FOR DERMIC ADMINISTRATION OF A SELECTIVE CYCLLOXYGENASA-2 INHIBITOR |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2003000759A true DOP2003000759A (en) | 2004-07-15 |
Family
ID=44261254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2003000759A DOP2003000759A (en) | 2003-11-20 | 2003-11-20 | ADHESIVE COATED SHEET FOR DERMIC ADMINISTRATION OF A SELECTIVE CYCLLOXYGENASA-2 INHIBITOR |
Country Status (1)
Country | Link |
---|---|
DO (1) | DOP2003000759A (en) |
-
2003
- 2003-11-20 DO DO2003000759A patent/DOP2003000759A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR042104A1 (en) | ADHESIVE COATED SHEET FOR DERMIC ADMINISTRATION OF A CYCLOOXYGENASE SELECTIVE INHIBITOR -2 | |
AR048827A1 (en) | APPARATUS AND METHOD FOR THE TRANSDERMAL ADMINISTRATION OF FENTANIL-BASED AGENTS | |
AR046697A1 (en) | METHOD AND SYSTEM OF TRANSDERMAL ADMINISTRATION OF AGENT ASSISTED BY FREQUENCY | |
JP2017039781A5 (en) | ||
HUP0401281A2 (en) | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals | |
BR0312671A (en) | Micro-needle device, method for using a micro-needle device, and method for applying a micro-needle device | |
EP2001453A4 (en) | Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia | |
MXPA06013168A (en) | Apparatus and method for transdermal delivery of parathyroid hormone agents. | |
TW200618830A (en) | Micorprojection apparatus and system with low infection potential | |
AR046824A1 (en) | COMPOSITION AND APPLIANCE FOR TRANSDERMAL ADMINISTRATION. | |
TW200502017A (en) | Active agent delivery device having composite members | |
JP2006525316A5 (en) | ||
MX2009013574A (en) | Modified release solid or semi-solid dosage forms. | |
WO2010009116A3 (en) | Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents | |
AR042102A1 (en) | DERMIC ADMINISTRATION OF A CYCLLOXYGENASA INHIBITOR - 2 WATER SOLUBLE SELECTIVE | |
BRPI0415986A (en) | method and apparatus for reducing the incidence of tobacco use | |
BRPI0417437A (en) | absorption inhibiting device, physiologically active agent removal device and overdose reduction device | |
MX2012002727A (en) | Transdermal therapeutic system for administering fentanyl or an analogue thereof. | |
JP2006525315A5 (en) | ||
BR0316436A (en) | Cyclooxygenase-2 Selective Inhibitor Plaster | |
DOP2003000759A (en) | ADHESIVE COATED SHEET FOR DERMIC ADMINISTRATION OF A SELECTIVE CYCLLOXYGENASA-2 INHIBITOR | |
PA8615501A1 (en) | PHARMACEUTICAL FORMULATIONS TRANSDERMICAS | |
AR054225A1 (en) | APPARATUS AND METHOD FOR TRANSDERMAL SUPPLY OF EPOYETINE-BASED AGENTS | |
AR127966A1 (en) | TOPICAL FORMULATIONS OF PI3K-DELTA INHIBITORS | |
DOP2003000758A (en) | DERMIC ADMINISTRATION OF A WATER SOLUBLE SELECTIVE CYCLLOXYGENASA-2 INHIBITOR |